Skip to main content

Table 1 Clinical studies related to dynamic respiratory microbiota in patients with invasive MV based on NGS analysis of respiratory tract samples

From: Effect of invasive mechanical ventilation on the diversity of the pulmonary microbiota

Study design

Duration

Region (country)

Patients groups/numbers

Age (years)

Antibiotics

Samples from

Targets

Sequencing platform

Conclusion regarding to microbiota change during invasive MV

Study

NA

NA

America (USA)

Invasive MV patients (15)

 ≥ 18

Yes for all patients

Oropharynx and trachea

16S rRNA

MiSeq (Illumina)

Diminished bacterial diversity in the two kinds of samples from patients with invasive MV

Kelly et al. [22]

Post hoc analysis

Sep. 2008–Sep. 2010

Europe (mainly Spain)

Invasive MV with VAP (11); Invasive MV without VAP (18)

 ≥ 18

Yes for all patients

Trachea

16S rRNA

454 GS FLX + (Roche)

Diminished bacterial diversity in invasive MV patients

Zakharkina et al. [23]

Prospective

Dec. 2015–Nov. 2016

Europe (Switzerland)

Invasive MV with VAP (5); Invasive MV without VAP (5)

 ≥ 18

Yes for 8 patients

Oropharynx and trachea

16S rRNA

MiSeq (Illumina)

No significant change

Sommerstein et al. [24]

Prospective case control

Oct. 2012–Mar. 2014

Europe (Switzerland)

Invasive MV with VAP (18); Invasive MV without VAP (36)

 ≥ 18

Yes for virtually all patients

Oropharynx and trachea

16S rRNA

MiSeq (Illumina)

Diminished bacterial diversity in invasive MV patients

Emonet et al. [25]

Prospective

Jul. 2017–Aug. 2018

Asia (Korea)

Invasive MV with pneumonia (41); Invasive MV without pneumonia (19)

 ≥ 18

Yes for most patients

Trachea

16S rRNA

MiSeq (Illumina)

Diminished bacterial diversity in invasive MV patients with pneumonia; No relevant result reported in invasive MV patients without pneumonia

Woo et al. [26]

Prospective

Aug. 2014–Aug. 2018

America (USA)

Invasive MV with oral suctioning intervention (9); invasive MV without oral suctioning intervention (7)

 ≥ 18

Yes for most patients (14/16)

Oropharynx and trachea

16S rRNA

MiSeq (Illumina)

Diminished bacterial diversity in invasive MV patients

Sole et al. [27]

Prospective

As of Jul. 2020

America (USA)

Invasive MV COVID-19 with VAP (16); Invasive MV COVID-19 without VAP (17)

 ≥ 18

Yes for all patients

Trachea

Total RNA with human cytosolic and mitochondrial ribosomal RNA depleted

NovaSeq 6000 (Illumina)

Diminished bacterial diversity in invasive MV COVID-19 patients

Tsitsiklis et al. [28]

Post hoc analysis

November 2015-November 2016

Germany

30 patients in two groups were enrolled in the study: 15 patients with sepsis-induced ARDS following major abdominal surgery and 15 patients undergoing esophageal resection (serving as controls)

 ≥ 18

Yes for all patients

Bronchoalveolar lavage (BAL)

16S rRNA

MiSeq (Illumina)

Decreased alpha diversity was associated with increased duration of mechanical ventilation (= 0.48, P = 0.009) and diversity. Patients with ARDS had lower alpha diversity in BAL compared to controls (Shannon index 3 (2; 3.6) versus 1 (0.5; 1.5); P = 0.007)

Schmitt et al. 2020

  1. NA: not available; ARDS acute respiratory distress syndrome